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C o n o to x in  g m 9 a , a  p u ta t iv e  2 7 - r e s id u e  p o ly p e p t id e  e n ­
c o d e d  b y  C o n u s  g lo r ia m a r is ,  w a s  r e c e n t ly  id e n t i f ie d  a s  a  
h o m o lo g u e  o f  t h e  “s p a s m o d ic  p e p t id e ”, tx 9 a , i s o la te d  
f ro m  t h e  v e n o m  o f  t h e  m o l lu s k -h u n t in g  c o n e  s h e l l  C o n u s  
te x t i le  (L ir a z a n , M . B ., H o o p e r ,  D ., C o rp u z , G . P ., R a m ilo , 
C . A ., B a n d y o p a d h y a y ,  P ., C ru z , L . J . ,  a n d  O liv e ra , B . M. 
(2000) B io c h e m is tr y  39, 1583-1588). T h e  C. g lo r ia m a r is  
s p a s m o d ic  p e p t id e  h a s  b e e n  s y n th e s iz e d ,  a n d  th e  r e ­
fo ld e d  p o ly p e p t id e  w a s  s h o w n  to  b e  b io lo g ic a l ly  a c t iv e  
u s in g  a  m o u s e  b io a s s a y .  T h e  c h e m ic a l ly  s y n th e s iz e d  
g m 9 a  e l ic i te d  t h e  s a m e  s y m p to m a to lo g y  d e s c r ib e d  p r e ­
v io u s ly  f o r  n a t iv e ly  fo ld e d  tx 9 a , a n d  g m 9 a  a n d  tx 9 a  w e r e  
o f  s im i la r  p o te n c y ,  im p ly in g  t h a t  n e i t h e r  t h e  tw o  y -ca r-  
b o x y g lu ta m a te  (G la) r e s id u e s  f o u n d  in  tx 9 a  (S e r8 a n d  
A la 13 i n  g m 9 a ) n o r  G ly 1 (S e r1 in  g m 9 a ) a r e  c r u c i a l  f o r  
b io lo g ic a l  a c t iv i ty .  W e h a v e  d e te r m in e d  th e  t h r e e ­
d im e n s io n a l  s t r u c t u r e  o f  g m 9 a  i n  a q u e o u s  s o lu t io n  a n d  
d e m o n s t r a t e d  t h a t  t h e  m o le c u le  a d o p ts  t h e  w e ll  k n o w n  
in h ib i to r y  c y s t in e  k n o t  m o t i f  c o n s t r a in e d  b y  t h r e e  
d is u l f id e  b o n d s  in v o lv in g  C y s2-C ys16, C y s6-C ys18 a n d  
C y s12-C ys23. B a s e d  o n  t h e  g m 9 a  s t r u c tu r e ,  t h e  s i te s  o f  
G la  s u b s t i t u t i o n  i n  tx 9 a  a r e  in  lo o p s  lo c a te d  o n  o n e  
s u r f a c e  o f  t h e  m o le c u le , w h ic h  is  u n l ik e ly  to  b e  in v o lv e d  
d i r e c t l y  in  r e c e p t o r  b in d in g .  B e c a u s e  t h i s  is  t h e  f i r s t  
s t r u c t u r e  r e p o r t e d  f o r  a  m e m b e r  o f  t h e  n e w ly  d e f in e d  
P - s u p e r f a m ily  c o n o to x in s , a  c o m p a r is o n  h a s  b e e n  m a d e  
w i th  s t r u c tu r a l l y  r e l a t e d  c o n o to x in s . T h is  s h o w s  t h a t  
t h e  s t r u c t u r a l  s c a f fo ld  t h a t  c h a r a c t e r i z e s  t h e  P -c o n o to x -  
in s  h a s  t h e  g r e a t e s t  p o te n t i a l  f o r  e x h ib i t in g  s t r u c t u r a l  
d iv e r s i ty  a m o n g  t h e  r o b u s t  in h ib i to r y  c y s t in e  k n o t- c o n ­
ta i n in g  c o n o to x in s ,  a  f in d in g  t h a t  h a s  im p l ic a t io n s  f o r  
fu n c t io n a l  e p i to p e  m im ic ry  a n d  p r o t e in  e n g in e e r in g .
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A novel Conus polypeptide was recently purified and char­
acterized from the venom of Conus textile, a Conus species 
known to hunt other snails (1). The new polypeptide defined a 
new class of venom components, the P-conotoxin superfamily, 
which has a distinctive cysteine framework, -CX3CX5CX3- 
CXCX4C-, where X  can be any amino acid. Conopeptides with 
three disulfide linkages and no half-cystines adjacent to each 
other have not been characterized previously (1, 2). The 
polypeptide purified from C. textile venom designated the 
“spasmodic peptide” is unusual in two respects. First, when 
injected into mice it phenocopied a well known mutant, the 
spasmodic mouse (3, 4). Second, in addition to the standard 
amino acids, this polypeptide has two residues of -y-carboxyglu- 
tamate (Gla),1 a distinctive post-translationally modified 
amino acid.
A second member of the P-superfamily was identified by 
molecular techniques from a different Conus species, Conus 
gloriamaris. The sequence of the latter was inferred from a 
cDNA clone (1). The predicted mature C. gloriamaris sequence 
is largely identical to the C. textile spasmodic peptide sequence, 
but it does not have the two glutamate codons presumably 
encoding Glu residues post-translationally modified to Gla. 
This polypeptide has not yet been isolated from C. gloriamaris 
venom. The sequences of the two mature P-superfamily 
polypeptides are shown in Fig. 1.
In this work, we have synthesized and refolded the C. glo­
riamaris polypeptide, gm9a, and assessed its activity in the 
same bioassay used to characterize tx9a. This has been done as 
a first step in understanding the molecular basis of the symp­
tomatology elicited by tx9a, which is unique among known 
conotoxins. Of particular interest is the significance of the 
post-translationally modified amino acids found in tx9a but not 
in gm9a. Further to this end, we have determined the three­
dimensional structure of gm9a in aqueous solution, which is 
expected to be homologous to that of tx9a considering the 
extent of sequence homology between the two polypeptides.
Because of their small size, robustness, and scope for struc­
tural diversity, conotoxins can be regarded as scaffolds that can 
be engineered for the mimicry of functional epitopes (5). In this 
context, the structures of the P-conotoxins are of interest be­
cause of their novel cysteine framework. In this work, we 
explore the structural consequences of the additional degrees of 
freedom in the molecular structure that result when no Cys
1 The abbreviations used are: Gla. ■y-carboxyglutamate; Fmoc. N-(9- 
fluorenyDmethoxycarbonyl; TCEP. Tris-[2-carboxyethyl]phosphine hy­
drochloride; HPLC, high performance liquid chromatography; ICK. in­
hibitory cystine knot; NOE. nuclear Overhauser effect.
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residues are directly adjacent in the polypeptide sequence. The 
gm9a structure is considered in comparison with structurally 
related conotoxins, particularly the well characterized O-super­
family conotoxins (6, 7).
EXPERIMENTAL PROCEDURES
Peptide Synthesis and Folding—Peptides were synthesized using 
standard solid-phase Fmoc protocol and standard side chain protections. 
The polypeptides were cleaved from solid support using reagent K (tri­
fluoroacetic acid:water:ethanedithiol:phenol:thioanisole, 90:5:2.5:7.5:5 by 
volume, respectively) for 3 h  at room temperature. The crude polypep­
tide was precipitated with cold methyl tot-butyl ether and washed 
three times with methyl tot-butyl ether. The linear form was purified 
using semi-preparative reversed-phase CIS HPLC. The identity of the 
linear polypeptide was confirmed by electrospray ionization mass spec­
trometry. Folding reactions were carried out at 0 °C and contained 0.1 
M Tris-HCl, 0.1 m M  EDTA, 1 m M  oxidized glutathione, 2 m M  reduced 
glutathione, pH 8.7, and 20 jjM linear polypeptide. After 24 h, the 
reaction was quenched by adding formic acid to 5% final concentration, 
and the mixture was separated by reversed-phase CIS HPLC in a linear 
gradient of acetonitrile in 0.1% trifluoroacetic acid from 9 to 31.5% in 20 
min. For analytical and semi-preparative CIS columns, flow rates of 1 
and 5 ml/min were used, respectively. All HPLC chromatography was 
monitored using absorbance a t 220 nm.
NMR Spectroscopy—A sample of gm9a was prepared for NMR anal­
ysis by dissolving the polypeptide in 0.30 ml of 90% H20 , 10% 2H20. The 
pH was adjusted to 5.5 with small additions of 0.5 M N a02H, and the 
solution was transferred to a 2H20-matched Shigemi tube (5-mm-outer 
diameter, 8-mm-bottom length,). Reported pH values were recorded at 
room temperature with no correction made for isotope effects. AH chem­
ical shifts were referenced to 2,2-dimethyl-2-silapentane-5-sulfonate at
0 ppm via the chemical shift of 1,4-dioxane at 3.75 ppm (8,).
NMR spectra were recorded on Bruker AMX-500 or DRX-600 spec­
trometers. All two-dimensional spectra were recorded in phase-sensi­
tive mode using the time-proportional phase incrementation method 
(9J. Water suppression was achieved either by pulsed field gradients 
employing the Watergate method of Sklenar et al. (10,i or by selective 
low power irradiation of the water signal during the relaxation delay 
(typically 1.8 s) and during the mixing time in NOESY experiments. 
Unless otherwise indicated, spectra were recorded at 5 °C. Two-dimen­
sional homonuclear NOESY spectra (9, 11) were recorded with mixing 
times of 75 and 250 ms. TOCSY spectra (12) were recorded using the 
MLEV spin-lock sequence (13) with a spin-lock time of 70 ms. DQF- 
COSY (14) and E-COSY (15) spectra were also recorded. Typically, 
spectra were acquired with tL = 400-500 increments, 32-128 scans/ 
increment, and 4096 data points. AH sweep-widths were 7575.8 and 
8992.8 Hz at 500 and 600 MHz, respectively. Spectra were processed 
using XWIN-NMR, version 1.3 (Bruker) and analyzed using XEASY, 
version 1.3.13 (16). Sine-squared window functions, phase-shifted by 
60-90“, were applied in both dimensions prior to Fourier 
transformation.
The V NHC„H coupling constants were measured from a DQF-COSY 
spectrum a t 500 MHz. The appropriate rows were extracted from the 
spectrum, inverse Fourier transformed, zero-filled to 64 K, and multi­
plied by a Gaussian window function prior to Fourier transformation.
The temperature dependence of each amide proton chemical shift 
was determined from one-dimensional spectra, recorded over the tem­
perature range of 5-30 °C. Slowly exchanging amide protons in the 
polypeptide were identified by dissolving the lyophilized polypeptide in 
2H20  (99.96% 2H, Cambridge Isotope Laboratories) at pH 5.5 and 5 °C 
and recording a series of one-dimensional and TOCSY spectra over 48 h. 
The chemical shifts of pH-dependent protons were monitored in a pH 
titration with TOCSY and one-dimensional spectra recorded at several 
values of pH in the range of 3.7-8.5 and 5 °C.
Structural Constraints—Upper bound distance constraints were cal­
culated from cross-peak volumes observed in a NOESY spectrum re­
corded with a 250-ms mixing time. These distance constraints were 
calibrated with the use of the CALIBA macro invoked in the torsion 
angle dynamics program DYANA (17) with volumes proportional to r 8 
for distances involving backbone protons and r 1 for all other distances. 
Distance constraints involving backbone atoms were loosened by a 
factor of 1.2 to allow for spin diffusion.
Backbone dihedral angle constraints were inferred from V NHC„H 
values as follows: 3J V , < 6 Hz, </> = -6 0  ± 30“; , > 8 Hz, </> =
-120 ± 30“. Where possible, 'VCn,HC/3H coupling constants were meas­
ured from passive couplings as displacements in an E-COSY spectrum. 
The relative intensities of intra-residue d„^i,i) and d Nf3(i,i) NOEs were
measured in a 75-ms mixing time NOESY spectrum. These 'VCn,HC/3H 
coupling constants and NOE intensities were used to determine 
whether side chains could be placed in one of the three-staggered 
side-chain rotamer conformations (.y1 = -60 , 60, or 180“) and to make 
stereospecific assignments.
Preliminary Structure Calculations—Preliminary structure calcula­
tions were performed in DYANA to facilitate the assignment of ambig­
uous NOE cross-peaks and to refine distance constraints. 200 struc­
tures were calculated from the refined list of structural constraints 
excluding disulfide bonds. To elucidate the disulfide connectivities in 
gm9a, these calculations were repeated with each possible combination 
of cysteine pairings constrained. The 20 lowest energy structures ob­
tained from each series of calculations were selected, and each family of 
structures was assessed on the extent to which they violated the NMR 
data. Prior to further refinement of the structures, disulfide-bond con­
nectivities were confirmed by chemical means (described below).
Structure Refinement and Analysis—Final structural calculations 
were performed in the CNS software suite (18) with disulfide bonds 
constrained. 200 structures were calculated in CNS via distance geom­
etry, simulated annealing, and low temperature-simulated annealing. 
The structures obtained were then energy minimized in a box of water 
using the OPLSX parameter set of Linge and Nilges (19). 20 structures 
were selected from 200 water-minimized structures on the basis of 
lowest energy terms associated with violation of experimentally derived 
constraints. Procheck (20) was used to identify elements of secondary 
structure in gm9a and to construct a Ramachandran plot of <p/«// angles 
in the family of 20 structures.
Verification of Disulfide Connectivities—To determine the pairing of 
Cys residues forming native disulfide bonds, we used the strategy 
described bv Grav (21). An equal volume of 20 mM TCEP (Pierce, 
Rockford, IL) in 0.2 M citrate buffer, pH 3.0, and folded gm9a in HPLC 
eluent were mixed and allowed to react for 20 min at room temperature. 
Typically, the reaction contained 5-10 nmol of polypeptide in 0.1-0.2 
ml. Resulting products were separated by reversed-phase HPLC using 
analytical C18 column (Vydac) in a linear gradient of acetonitrile (in
0.1% trifluoroacetic acid) "from 13.5% to 22.5% in 20 min. The HPLC 
peaks were immediately subjected to rapid alkylation using saturated 
iodoacetamide solution. The iodoacetamide (0.1 g) was dissolved in 0.2 
ml of 0.5 M Tris acetate buffer, 2 mM EDTA, pH 8.0, and the solution 
was heated to 65 °C until the solid was dissolved. 10 ju,l of 100 mM 
ascorbic acid was added to the iodoacetamide solution to scavenge 
possible traces of iodine, and then 0.3 ml of the partially reduced 
intermediate in HPLC eluent was rapidly injected into the cooled 
iodoacetamide solution using a fine-tipped syringe and mixed vigor­
ously for 30 s. The alkylation was then quenched with 0.5 M citric acid 
(0.4 ml), and the mixture was separated on a C18 analytical HPLC 
column. The following elution conditions were developed to separate 
alkylation products: 20 min of 9% acetonitrile in 0.1% trifluoroacetic 
acid (isocratic) followed by a linear gradient of acetonitrile (9-45% for 
20 min) and flow rate of 1 ml/min. The resulting disulfide intermedi­
ates, which contained some pairs of carboxymethylated Cys residues, 
were further reduced with dithiothreitol and alkylated with 4-vinylpyri- 
dine. The HPLC eluent containing the intermediates was adjusted to 
pH 8.0 by adding 0.5 M Tris base solution. The intermediates were 
reduced in 10 mM dithiothreitol at 65 °C for 15 min. After the solution 
was cooled, 3 ju,l of 4-vinylpyridine was added for every 0.5 ml of the 
sample volume. The alkylation reaction was carried out in the dark at 
room temperature for 25 min and then diluted with 0.1% trifluoroacetic 
acid and injected on a C18 analytical HPLC column. The HPLC condi­
tions were similar to those described above with the exception of the 
linear acetonitrile gradient applied (9-27% in 20 min). The final alky­
lation products were sequenced using a standard Edman protocol. 
Positions of carboxymethylated and pyridylethylated cysteines were 
determined from the sequencing data.
RESULTS
Chemical Synthesis o f gmSa—To further define the newly elu­
cidated P-superfamily (1), we chemically synthesized and folded 
conotoxin gm9a (sequences in Fig. 1) also called the C. glo- 
riamaris spasmodic peptide. The biologically active conotoxin 
was first synthesized as a linear chain using standard Fmoc 
protocol. Cleavage and deprotection was achieved by incubating 
resin with reagent K as specified under “Experimental Proce­
dures.” The linear form was purified using semi-preparative re- 
versed-phase C18 HPLC. The identity of the synthetic polypep­
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Structure o f P-conotoxin gm9a 43035
Fig. t .  Amino acid  sequences tx9a an d  gm9a. Sequences of the 
tx9a and gm9a polypeptides from C. textile and C. gloriamaris, respec­
tively (GenBank™  accession numbers AF193510 and AF193511, re­
spectively). In the  tx9a sequence, y  represents th e  non-standard amino 
acid Gla. The locations of disulfide bonds determined in this paper are 
indicated.
To obtain a cyclic polypeptide with disulfide bridges, we used 
a direct oxidation method in which the polypeptide containing 
six unprotected cysteines was allowed to form disulfides under 
oxidizing conditions. The linear polypeptide was treated with 
the mixture of oxidized and reduced glutathione. The folding 
reaction contained 0.1 m  Tris-HCl, 0.1 m M  EDTA, 1 m M  oxidized 
glutathione, 2 m M  reduced glutathione, pH 8.7, and linear 
polypeptide (20 fm ). Folding was carried out at 0 °C for 24 h. 
The acid-quenched reaction mixture was separated by re- 
versed-phase C18 HPLC. A major folding product was purified 
and characterized using the mouse bioassay previously em­
ployed for the C. textile spasmodic peptide (1). Qualitatively, 
the biological activity of purified synthetic gm9a was similar to 
that described previously for tx9a, the spasmodic peptide iso­
lated from the venom of C. textile (1). Both peptides elicited the 
spasmodic symptomatology described previously (1). A direct 
comparison between the two peptides demonstrated that both 
caused hypersensitivity to touch in mice when injected at a 
dose of 2 nmol and hyperactivity and convulsions at 5 nmol.2
N M R  Spectroscopy—NMR spectra for structural analysis 
were collected on the gm9a polypeptide in 90% H20 , 10% 2H20  
at pH 5.5. Broad NH chemical shift dispersion in one-dimen­
sional spectra indicated that the polypeptide was well struc­
tured, and standard two-dimensional spectra recorded at 5, 15, 
and 25 °C showed that only one conformation was present in 
aqueous solution at these temperatures. Most amide peaks 
were well resolved at all of these temperatures, and many 
values of the 3JNaCaH coupling constants were apparent from 
the one-dimensional spectra at 500 MHz. Sequence-specific 
chemical shift assignments were made at 600 MHz for back­
bone and side-chain protons in gm9a with the aid of standard 
two-dimensional homonuclear NMR experiments. These as­
signments are provided as supplementary data (Table S-I) and 
have been deposited with BioMagResBank (22) under accession 
number BMRB-6086. Distance constraints were taken from the 
volumes of NOE cross-peaks in NOESY spectra acquired at 
5 °C at 600 MHz.
In general, spectral overlap was minimal, but overlap in the 
regions of the Cys CPH and NH resonances made it difficult to 
assign unambiguously a small number of NOE cross-peaks that 
might have assisted in the identification of Cys-Cys bonds. 
Most of these ambiguities were resolved by conducting experi­
ments a t different temperatures and different pH values to 
disperse chemical shifts of key protons. Despite this, direct 
identification of Cys-Cys connectivities remained problematic 
as a number of Cys C“H and CPH had through-space NOE 
cross-peaks with more than one other Cys, indicative of a 
cluster of Cys side-chains in the polypeptide.
A suite of NMR experiments yielded distance and torsion 
angle constraints for use in structural calculations. Initial cal­
culations were performed in DYANA with no disulfide or hy­
drogen bonds present. The family of 20 best structures obtained
2 E. C. Jim enez, unpublished results.
Fig. 2. C hem ical verifica tion  of d isulfide connectiv ity  in  gm9a.
The folded gm9a was partially  reduced using 20 him TCEP a t pH 3.0 for 
20 min and separated by reversed-phase HPLC. The disulfide connec­
tivities of resulting interm ediates were determined by differential al­
kylation of Cys thiols with iodoacetamide and 4-vinylpyridine followed 
by Edman sequencing. Peaks labeled N  and I i  correspond to th e  folded 
and fully reduced forms, respectively. Interm ediates A and C are shown 
with th e ir deduced disulfide connectivity. Interm ediate B  could not be 
fu rther analyzed because of intram olecular rearrangem ent during al­
kylation of thiols. The minor peaks between N and A arise from reagent 
contamination. Experim ental details of reduction and alkylation are 
described under “Experim ental Procedures.”
with no disulfide bonds imposed was used as a reference to 
determine the disulfide-bonding pattern in gm9a that was most 
consistent with the NMR data.
Structural constraints were well satisfied for every combina­
tion involving either the Cys2-Cys16 or Cys6-Cys18 pairings 
(Table S-II from supplementary data), and the lowest target 
function was obtained when both of these bonds were in place, 
i.e. the combination of Cys2-Cys16, Cys6-Cys18, and Cys12- 
Cys23. The structures derived with this combination of disul­
fides used to constrain the molecule showed that gm9a adopts 
the inhibitory cystine knot (ICK) motif (7, 23), a common struc­
tural motif incorporating a cystine knot and a triple-stranded 
/3-sheet in toxic and inhibitory polypeptides.
Chemical Verification o f D isulfide Connectivity in  gm9a— 
The disulfide connectivities consistent with the NMR data were 
confirmed chemically before the final structure calculations 
were undertaken. The general strategy involved a partial re­
duction of the folded gm9a at acidic pH followed by a primary 
alkylation of the resulting Cys thiols with iodoacetamide. The 
alkylation products were isolated by reversed-phase HPLC, 
further reduced with dithiothreitol, and subjected to a second­
ary alkylation with 4-vinylpyridine. The Cys connectivities 
were deduced using standard Edman sequencing by identifica­
tion of positions of carboxymethyl- and pyridylethyl-modified 
cysteines.
Fig. 2 shows the HPLC separation of products after TCEP 
reduction of the folded gm9a for 20 min at pH 3.0. Three major 
intermediates were purified and alkylated with iodoacetamide 
as described under “Experimental Procedures.” Two interme­
diates (Fig. 2, peaks labeled A  and C) yielded clear alkylation 
products. However, intermediate B apparently underwent a 
rearrangement during alkylation as judged by multiple alky­
lation products observed after HPLC analysis (data not shown). 
Therefore, only alkylated intermediates A and C were further 
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The polypeptides were reduced for 15 min at 65 °C using 10 
m M  dithiothreitol followed by addition of 4-vinylpyridine. After 
secondary alkylation, the polypeptides were purified by HPLC 
and sequenced. Intermediate A contained carboxymethylated 
cysteines at positions 6 and 18 and pyridylethylated cysteines 
at positions 2, 12, 16, and 23. Intermediate C contained car­
boxymethylated cysteines at positions 2, 6, 16, and 18 and 
pyridylethylated cysteines at positions 12 and 23. Based on 
these data, we deduce that the disulfide connectivity of biolog­
ically active gm9a is Cys2-Cys16, Cys6-Cys18, and Cys12-Cys23, 
which is the combination most consistent with the NMR data.
N M R Assessment o f Hydrogen Bonds—The temperature de­
pendence of the chemical shift of each gm9a amide proton was 
determined to probe for hydrogen bonding. However, all amide 
protons exhibiting a temperature coefficient of magnitude <3 
ppb/°C (Table S-III from supplementary data ) were found to be 
from either cysteines (16, 18, 23) or residues directly adjacent 
to cysteines (5, 7, 11, 24). Because structure calculations indi­
cated tha t the three disulfides form the core of folded gm9a, the 
low susceptibility of these amide chemical shifts to a change in 
temperature presumably reflects the location of these protons 
in the polypeptide core rather than their involvement in hydro­
gen bonding (24). Amide exchange experiments conducted at
5 °C and pH 5.5 indicated that all amide protons with the 
exception of those of Gin7 and lie17 exchanged with solvent 
deuterium within minutes of dissolution of the polypeptide in 
2H20. Amide protons from these two residues were apparent in 
NMR spectra for several hours following dissolution; however, 
again these residues are directly adjacent to core Cys residues. 
Because the experimental indicators of hydrogen bonding could 
have been influenced by reduced solvent accessibility, no hy­
drogen bonds were used as distance constraints in structural 
calculations.
Solution Structure o f Conotoxin gm 9a—Parameters charac­
terizing the final 20 structures of gm9a and structural statis­
tics are summarized in Table I, and stereoviews of the struc­
tures superimposed over the backbone are shown in Fig. 3. 
These structures were calculated with the chemically deter­
mined disulfide bonds intact. Table I indicates that the final 20 
structures fit well with experimentally derived distance and 
angle constraints and are well defined over the entire length of 
the polypeptide. The structures of gm9a have been deposited 
with the Protein Data Bank (PDB accession number 1IXT) (25).
Different features of the closest-to-mean gm9a structure are 
highlighted in Fig. 4. In terms of overall topology, the molecule 
has a sulfur-rich core of three disulfides that form an inhibitory 
cystine knot as illustrated in Fig. 4E and a backbone made up 
of three extended sections encompassing residues 1^6, 15^19, 
and 22^27 and three loops centered on residues 7—11, 12^14, 
and 20^21. Procheck (20) was used to identify elements of 
secondary structure in the final family of gm9a structures. The 
most prominent feature of the structures is a 0-hairpin in the 
COOH-terminal half of the molecule (Fig. 4, A and B) with 
the first extended j3-strand encompassing His16-Thr19, and the 
second extended j3-strand encompassing Gly22-Ala26. The loop 
at the center of the hairpin (Phe20 and Arg21) was identified as 
a hydrogen-bond-stabilized Type I turn. Procheck also identi­
fied an isolated j3-bridge at Asn4 tha t is hydrogen-bonded 
through its carbonyl to Cys23 in the second j3-strand (26). How­
ever, all of the residues in the range Cys2-Cys6 occupied the 
j3-sheet region of the Ramachandran plot, suggesting that 
gm9a contains a triple-stranded anti-parallel j3-sheet in com­
mon with many ICK-containing conopeptides (7). The fact that 
this extended region is constrained at either end by a disulfide- 
bonded Cys (Cys2 and Cys6) may distort the backbone from 
ideal j3-strand geometry. The final structures also contain hy-
T a b l e  I 
Structural statistics for gm9a
No. of NOE-derived distance constraints 
Total
Intraresidual and sequential 
Medium range 
Long range backbone 
Long range 
No. of dihedral angle constraints 
No. of if angle constraints 
No. of x’1 angle constraints 
Constraint violations 
No. of distance violations > 0.2 A 
No. of dihedral violations > 5 "  
r.m.s. deviations from experimental 
constraints" J'
439-interproton distance constraints (A) 
26 dihedral angle constraints (°) 




Backbone atoms r.m.s. deviations (Af 
All heavy atoms r.m.s. deviations (A)rf 
Ramachandran plot 
% in favored region 
% in additionally allowed region 











0.025 ± 0.001 
0.554 ± 0.174
0.0048 ± 0.0002 
0.481 ± 0.046 
0.373 ± 0.053 





° Average values ± S.D. calculated for the 20 final structures.
* Best values for the 20 final structures.
'■ Average pairwise r.m.s. deviations of atomic coordinates C', C", and 
N for residues 1-27 across the 20 final structures.
rf Average pairwise r.m.s. deviations of all atoms excluding hydrogen 
for residues 1-27 across the 20 final structures.
drogen bonds between strands and across all three loops (Table 
S-III from supplementary data). The disulfides formed by Cys2- 
Cys16 and Cys12-Cys23 adopt a left-handed conformation, 
whereas the remaining disulfide, Cys6-Cys18, is right-handed.
gm9a contains only three charged residues at physiological 
pH, namely Asp11, Arg21, and the protonated N terminus, Ser1. 
As illustrated in Fig. 4, C and D, the positively charged centers 
on Ser1 and Arg21 are in close proximity to each other on one 
face of the molecule, and the negatively charged Asp11 is on the 
opposite face. Fig. 4F  shows the distribution of hydrophobic 
residues in gm9a, which occur principally on the same face as 
the cationic residues and on the opposite face to Asp11, which is 
located on a surface composed mainly of polar residues. Also 
shown is the location of the Gla substitutions (Ser8 and Ala13 ) 
in tx9a, which are situated on the Asp11 face of the molecule.
An unexpected feature of the spectra was a broad peak at
11.3 ppm in one- and two-dimensional spectra recorded at pH 
5.5. This resonance showed NOESY cross peaks to side-chain 
protons on lie17 and Cys18. Spectra recorded over a range of pH 
showed that the chemical shift and line width of this peak were 
highly dependent on pH, indicating that the proton was in 
exchange with solvent protons. An analysis of the final struc­
tures indicate tha t the only exchangeable peak in sufficiently 
close proximity to the side-chains of lie17 and Cys18 is the 
imidazole proton of His9. This is supported by its chemical 
shift, which is consistent with that of a His side-chain NH 
(22, 27).
A limited pH titration was undertaken to determine the pKa 
values for the imidazolium groups of His9 and His16 and the 
carboxyl of Asp11. As summarized in Table S-IV from supple­
mentary data, the imidazolium pKa values were 4.9 and 6.0, 
respectively, and the carboxyl p-K^  value was 4.8. In small 
histidine-containing peptides the imidazolium pKa was 7.0 at 
35 °C (28), whereas in the uncharged model compound Ac-His- 
NHMe, it was 6.38 at 37 °C (29), 6.43 in H20, and 6.54 in 2H20, 
each containing 0.1 m  NaCl at 30 °C (30). The intrinsic pKa 
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Fig. 3. gm9a s tru c tu res . Stereoviews 
of the family of 20 final structures deter­
mined for gm9a superimposed over back­
bone heavy atoms from all 27 residues. 
For clarity, amino acid side-chains have 
been eliminated from the family of struc­
tures in the top view. Side-chain orienta­
tions are shown for the elosest-to-mean 
structure in the bottom view. Disulfide 
bonds are shown in gray. The letters N  
and C refer to the amino and carboxyl 
termini, respectively.
9 D 21 ----  r*ii
Fig. 4. A spects of th e  gmf)a stru c tu re . A  and B, ribbon diagrams representing the elosest-to-mean gm9a structure where the two perspectives 
are related by a 180° rotation along the y  axis, and yellow arrows indicate |3-strands. C and D, simple charge distribution on the surface of gm9a 
and are shown in the same orientation as A and B, respectively. Electrostatic potentials are color-coded blue for the positively charged residues 
Ser1 and Arg21 and red for the negatively charged residue Asp11. E, a ribbon representation of the gm9a backbone, which demonstrates the 
inhibitory cystine knot motif where the Cys12-Cys23 disulfide bond passes through a loop constrained by the Cys2-Cys16 and Cys6-Cys1!< disulfides. 
In E, disulfide bonds are shown in yellow, and the backbone of residues forming the loop are shown in violet. F, the elosest-to-mean structure 
obtained for gm9a with the location of Ser* and Ala13 indicated, which are sites of Gla substitution in the tx9a polypeptide. In F, Arg21 and Ser1 
are in blue, hydrophobic residues (lie17, Phe20, Ala25, and Val26) are shown in coral (excluding Ala13), Asp11 is in red, and the sites of Gla 
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43038 Structure o f P-conotoxin gm9a
Fig. 5. E xperim en ta l s tru c tu re s  o f conotoxins w ith  th e  sam e d isulfide-bonding p a tte rn  as gm9a. A-L, smoothed ribbon representa­
tions of the backbone of experimentally derived conotoxin structures. The amino acid sequences corresponding to these structures are given in 
Table 11. The structures were downloaded from the Protein Data Bank (25 > and correspond as follows: A. G111B (34,); B. G111A (35,); C. i^-PlllE (36,); 
D. TV11A. (37,); E. conotoxin GS (38,); F  and G. tram- and ris-isomers of EV1A. respectively (PDB codes 1G1P/1G1Z,); U, S03 (PDB code 1FYG,); I. 






lower than the model values, consistent with its largely sol­
vent-exposed environment. The significantly lower pKa for His9 
is consistent with its location on the surface but in close contact 
with several non-polar side chains to which it shows numerous 
NOEs (lie17 and Cys18). These interactions are expected to 
favor the neutral form and thus reduce the pKa. It is probable 
that protonation of the imidazole side chain causes some local 
conformational changes associated with movement of the pos­
itively charged ring to a more solvent-exposed environment 
and that changes in the chemical shifts of lie17 methyl reso­
nances as this titration occurs probably reflect this. His9 is not 
close to the Arg21 side chain or the N-terminal ammonium 
group, so direct effects of either of these positively charged 
groups are unlikely to contribute to its low pKa.
The C^H resonances of Asp11 in gm9a titrate with a pKa of
4.8 (Table S-IV from supplementaiy data) significantly higher 
than the carboxyl group of Asp in small peptides with a pKa of
3.9 (28, 32). Even though the direction and magnitude of the 
chemical shift changes associated with this titration are as 
observed in small peptides (28), it is nevertheless possible that 
this pKa reflects the titration of His9 rather than the Asp11 
carboxyl. The two side chains are not in close proximity; how­
ever, both residues are located on a reverse turn (distorted 
Type I involving His9 and Ser10), so it is possible that local 
conformational changes associated with the titration of His9 
could affect the environment of Asp11. If the pKa of 4.8 does 
reflect the carboxyl titration, then it is unusually high. As in 
the case of His9, Asp11 is located on the surface but is in close 
contact with several other side chains (residues 6, 7, 8, 10, and 
12) to which it shows numerous NOEs. These interactions 
would be expected to favor the neutral form and thereby raise 
the carboxyl pKa.
DISCUSSION
Lirazan et al. (1) recently identified conotoxin tx9a from the 
venom of the cone shell C. textile and argued that it defined a 
new class of conotoxins, the P-superfamily, on the grounds that 
it had a novel cysteine framework (-CX3CX5CX3CXCX4C-) and 
precursor structure and was pharmacologically distinct from 
other conotoxins. A second polypeptide that had high sequence 
identity with tx9a including the distinctive Cys framework was 
identified in that work from C. gloriamaris. In this work, we 
have synthesized the gm9a polypeptide from C. gloriamaris 
and determined that it is pharmacologically related to tx9a. We 
have found these polypeptides to be indistinguishable in an in 
vivo assay in mice in which both the polypeptides phenocopy 
the spasmodic mouse m utant (3, 4). In this mouse, there are 
alterations in glycine receptors, but the molecular target of the 
Conus polypeptides in the central nervous system has not yet 
been determined (1).
Functional Diversity among Conotoxins—One of the tenets of 
structural genomics is that structure provides clues regarding 
function, but it has been pointed out that this nexus generally is 
weak in the case of polypeptide toxins (33). This is certainly true 
of the conotoxins where functional diversity is achieved by a 
combination of sequence variation and structural variation. As a 
result, structural analysis reveals few clues as to the potential 
molecular target of a given polypeptide. Fig. 5 shows ribbon 
representations of several conotoxin structures that contain six 
Cys residues and exhibit the same disulfide-bonding pattern 
exhibited by gm9a, namely C,-C4/C2-C5/C3-C6. Further details of 
these conopeptides are given in Table II.
ju-GIIIA, ju-GIIIB, and i/»-PIIIE (Fig. 5, A, B, and C, respec­
tively, and Table II) all share a common Cys framework 
(-CCX4_5CX4_5CX4CC-) and the C1-C4/C2-C5/C3-C6 bonding 
pattern (2). These polypeptides are similarly structured but 
functionally distinct. The ^.-conotoxins bind selectively to so­
dium channels (34, 35, 44), and i/»-PIIIE inhibits the acetylcho­
line receptor (36). An analogous situation exists among the Gi­
an d K-O-superfamily conotoxins (Fig. 5, H-K). All of these 
polypeptides exhibit the ICK motif within the same Cys frame­
work (-CX6CX6CCX2„3CX4„6C-), and despite significant se­
quence diversity, even among the <o-conotoxins, all have a re­
markably similar structure. However, the <o-conotoxins S03 
iff), MVIIA (I), and GVIA (J) all selectively inhibit voltage- 
gated calcium channels (41, 42), and PVIIA (K ), a K-conotoxin, 
selectively inhibits Shaker potassium channels (43). In con­
trast is conotoxin GS (E), which is structurally related to the 
O-conotoxins through a common Cys framework and ICK motif 
but is functionally related to the ^.-conotoxins as it binds com­
petitively with ju-GIIIA to skeletal muscle sodium channels 
(38). This is complicated further by the fact that conotoxin GS 
has low sequence identity with either GIIIA or GIIIB and is 
50% larger.
Structural Diversity within Superfamilies—Despite having a 
Cys framework in common, there can also be significant struc­
tural diversity among members of a given superfamily. This 
diversity can be attributed mainly to the different inter-cys­
teine spacings across the sequences and is well illustrated by 
considering the structural variation among the O-superfamily 
polypeptides ( Fig. 5, D-K), all of which have a common Cys 
framework and exhibit the ICK motif.
There is significant sequence variation among gj-S03 (Fig. 5, 
ff), gj-MVIIA (7), gj-GVIA (J), and k-PVIIA (K), even though 
they have very similar structures. An inspection of Table II 
shows that the number of residues between sequential cys­
teines is reasonably consistent across the four polypeptides, i.e.
6 (Cr C2), 6 (C2-C3), 0 (C3-C4), 2-3 (C4-C5), and 4 -6  (C5-C6). By 
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Structure o f P-conotoxin gm9a
Table II
Description o f various conopeptides that have the same disulfide-bonding pattern as gm9a
43039
Peptide Sequence0 c, -  c u ,6 Ref.
A-GIIIB RDCCTXXRKCKDRRCKXMKCCA Conus geographus 0, 5, 4, 4, 0 (34)
B-GIIIA RDCCTXXKKCKDRQCKXQRCCA C. geographus 0, 5, 4, 4, 0 (35)
C-PIIIE HXXCCLYGKCRRYXGCSSASCCQR Conus purpurascens 0, 4, 5, 4, 0 (36)
D-TVIIA SC SGRDSRCXXVCCMGLMC SRGKCVSIYGE Conus tulipa 6, 3, 0, 4, 4 (37)
E-GS AC SGRGSRCXXQCCMGLRCGRGNPQKCIGAH-/DV C. geographus 6, 3, 0, 4, 7 (38)
F-EVIA,m„ . DDCIKXYGFC SLPILKNGLCC SGACVGVCADL Conus ermineus 6, 9, 0, 3, 3 (PDB 1GIP)
G-EVIAtl . DDCIKXYGFC SLPILKNGLCC SGACVGVCADL C. ermineus 6, 9, 0, 3, 3 (PDB 1GIZ)
H-S03 CKAAGKPC SRIAYNCC TGS CRSGKC C. striatus 6, 6, 0, 3, 4 (PDB 1FYG)
I-MVIIA CKGKGAKCSRLMYDCC TGSCRSGKC Conus magus 6, 6, 0, 3, 4 (41)
J-GVIA CKSXGSSCSXTSYNCCRSCNXYTKRCY C. geographus 6, 6, 0, 2, 6 (42)
K-PVIIA CRIXNQKCFQHLDDCCSRKCNRFNKCV C. purpurascens 6, 6, 0, 3, 5 (43)
L-gm9a SCNNSCQSHSDCASHCICTFRGCGAVN C. gloriamaris 3, 5, 3, 1, 4 (1 )
M-tx9a SCNNSCQ^HSDCO' SHCICTFRGCGAVN C. textile 3, 5, 3, 1, 4 (1 )
“ Cysteines are shown emboldened, residues with charged side chains at physiological pH are underlined, y represents Gla, and X represents 
hydroxyprolines.
b Each number series refers to the number of residues between sequential cysteines in the polypeptide sequence i.e. the number of residues 







4, and 7 and a structure that differs from the a>- and K-cono- 
toxins. In TVIIA (D), these spacings are 6, 3, 0, 4, and 4, and as 
a consequence, it has essentially the same structure as cono­
toxin GS over the disulfide-linked region of the molecule with 
the exception that the loop between C5 and C0 is approximately 
half as large in TVIIA (Fig. 5). A similarly significant departure 
from the classic &)-conotoxin fold is observed in EVIA (G), which 
has the spacings of 6, 9, 0, 3, and 3. When this type of analysis 
is applied to the P-conotoxin gm9a in which 3, 5, 3, 1, and 4 
residues separate sequential Cys residues, it is readily appar­
ent why the structure of this polypeptide is unique among those 
shown in Fig. 5.
In light of this analysis, two points can be made with regard 
to the newly defined P-conotoxins. First, because the number of 
residues between sequential half-cystines is a significant indi­
cator of structural variation and as new members of this family 
of conopeptides are identified, this source of structural diver­
sity can be used to assess the extent of their homology with 
gm9a. Second, because the P-conotoxins have no cysteines di­
rectly adjacent to one another, the scaffold underlying this 
superfamily of polypeptides has the greatest scope for exhibit­
ing structural and functional diversity among all of the six 
Cys-containing conotoxins. This latter point has significant 
implications for protein engineering and functional epitope 
mimicry (40, 45). An inspection of the structure of gm9a sug­
gests that the loops between the second and third half-cys­
teines and the fifth and sixth are potentially the most suitable 
for the introduction of new sequences.
Im plications for tx9a from  C. textile—Chemically synthe­
sized gm9a, the C. gloriam aris spasmodic peptide, has bio­
logical activity comparable to th a t elicited by the C. textile 
spasmodic peptide in an in vivo assay in mice (1). The two 
spasmodic peptide sequences from C. textile (tx9a) and C. 
gloriam aris (gm9a) differ in only three positions, with Ser1, 
Ser8, and Ala13 in gm9a substituted for Gly, Gla, and Gla, 
respectively, in tx9a. We expect tx9a to adopt a conformation 
similar to th a t of gm9a, because the location of the six Cys 
residues is identical in the two polypeptides, the substitution 
at the flexible N terminus is not likely to be structurally 
significant, and the two Gla substitutions involve neither 
glycine nor proline residues, mutations th a t might be ex­
pected to yield structural variation. In addition, it was dem­
onstrated by Hill et al. (38) th a t substituting Gla for Glu in 
conotoxin GS resulted in no change in the backbone confor­
mation of th a t polypeptide.
The nature of the molecular target of gm9a and tx9a remains 
undefined, but the symptomatology elicited by both polypep­
tides is reminiscent of spasmodic and spastic mouse mutants
(3, 4), which were characterized as being defective in glycine 
receptors. Although the receptor for these polypeptides is still 
to be determined, it is apparent from the comparable results of 
the mouse assays that the two y-carboxyglutamates in tx9a are 
not involved directly in receptor binding.
An analysis of the gm9a structure shows that residues 8 and 
13 (Fig. 4F) are found on the same face of the molecule, flank­
ing the only acidic residue Asp11. One consequence of this 
finding is that on one face of the molecule, tx9a is substantially 
more electronegative than is gm9a. This is significant because 
in the main, conotoxins are rich in basic side-chains (see Table
II) that interact with anionic sites in their ion channel recep­
tors. This also implies that this region of the molecular surface 
does not constitute the receptor-binding interface of these 
polypeptides. Rather, it can be inferred that the polar face of 
these molecules is solvent-exposed when the polypeptides bind 
their target and that the binding epitope is probably on the 
hydrophobic/cationic face of the molecule.
-y-Carboxyglutamates have been implicated in Ca2" binding 
by Prorok et al. (39), who demonstrated that the Gla-rich 
Coraws-derived conantokins T and G were susceptible to confor­
mational change as a result of calcium binding to Gla residues. 
In these polypeptides, however, Gla residues are in close prox­
imity to one another with some being adjacent in the se­
quences. Hill et al. (38) considered the possibility that the 
single Gla residue in conotoxin GS might be involved in Ca2" 
binding. They demonstrated by NMR that there was no confor­
mational change in the polypeptide observable in the presence 
of calcium ions and found no evidence of line broadening or 
perturbation of Gla32 side-chain resonances that might indi­
cate calcium binding. It was concluded that this single residue 
might not play a crucial role in either the structure or function 
of conotoxin GS.
tx9a has two Gla residues, but inspection of the gm9a struc­
tures indicates that across the family of 20 structures, residues 
8 and 13 are always >10-A apart. Clearly, this is too large a 
distance for these residues to cooperatively chelate Ca2 " ions in 
the folded structure. However, it is conceivable that one or 
other of the Gla residues and the intervening Asp11 could 
participate in Ca2" binding in tx9a. It is also possible that 
these Gla residues could be involved in the folding of the tx9a 
polypeptide. Prorok et al. (39) found that Ca2 " binding induced 
an increase in the a-helical content of the conantokins consid­
ered in their work. In gm9a and presumably in tx9a, residues 
8 and 13 are found in the loops of the molecule. In tx9a, the 
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